Tutorials
TSE:4519 (Japan)  
Chugai Pharmaceutical Co Ltd logo

Chugai Pharmaceutical Co Ltd

円 3770.00 (+1.97%) Aug 5
P/E:
15.94
P/B:
4.74
Market Cap:
円 6.20T ($ 45.88B)
Enterprise V:
円 5.61T ($ 41.50B)
Volume:
1.91M
Avg Vol (2M):
2.78M
Also Trade In:
Volume:
1.91M
Market Cap 円:
6.20T
Market Cap $:
45.88B
PE Ratio:
15.94
Avg Vol (2-Month):
2.78M
Enterprise Value 円:
5.61T
Enterprise Value $:
41.50B
PB Ratio:
4.74
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Chugai Pharmaceutical Co Ltd
NAICS : 325412
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Description
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines, primarily focused on oncology, renal diseases, and bone and joint diseases. It is an industry leader in antibody technology with several notable therapies, including Hemlibra for hemophilia patients and Actemra for rheumatoid arthritis.

Financials (Next Earnings Date:2022-10-24)

TSE:4519's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 1,205,697
EPS (TTM) (円) 236.44
Beta 0.89
Volatility % 23.63
14-Day RSI 56.87
14-Day ATR (円) 91.439899
20-Day SMA (円) 3703.05
12-1 Month Momentum % -10.93
52-Week Range (円) 3258 - 4490
Shares Outstanding (Mil) 1,644.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Chugai Pharmaceutical Co Ltd Filings

Document Form Filing Date
No Filing Data